Aurobindo Pharma’s step-down subsidiary -- Lannett Company LLC has launched the generic equivalent of Advair Diskus (fluticasone propionate and salmeterol inhalation powder), a product of GSK plc, in 100/50 mcg and 250/50 mcg strengths, in the US market. Lannett Company LLC is a wholly owned subsidiary of Aurobindo Pharma USA, Inc., which is a wholly owned subsidiary of the company.
This launch marks the first product from the company’s inhalation pipeline to be commercialized in the US, reflecting its continued focus on expanding its portfolio of complex and differentiated inhalation products. Advair Diskus in combination therapy is indicated for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.
